Lasa Supergenerics
Lasa Supergenerics Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Lasa Supergenerics Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Valuation
Profitability
Growth
Financial Health
Lasa Supergenerics Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Lasa Supergenerics Ltd, switchable between annual and quarterly views, consolidated or standalone.
Lasa Supergenerics Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹35.62 Cr and reported EPS of ₹-8.83.
Lasa Supergenerics segment analysis: revenue and profit mix.
Disclosed business segments at Lasa Supergenerics with their share of revenue and profit, switchable between consolidated and standalone reporting.
Lasa Supergenerics discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Lasa Supergenerics Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Lasa Supergenerics Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
What you're getting.
No strengths or opportunities on record.
What can break it.
No weaknesses or threats on record.
What would change my mind.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 20.14. Balance sheet risk re-prices growth multiples fast.
Lasa Supergenerics Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Lasa Supergenerics Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Lasa Supergenerics Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Lasa Supergenerics Ltd — derived from the live tape, not yesterday's close.
Lasa Supergenerics Ltd last traded at ₹7.13 with an intraday range of ₹6.76–₹7.54 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹7.13| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 9.09 | +1.96 | +27.44% |
| R3 | 8.31 | +1.18 | +16.50% |
| R2 | 7.92 | +0.79 | +11.13% |
| R1 | 7.53 | +0.40 | +5.56% |
| PIVOT | 7.14 | 0.01 | 0.19% |
| CURRENT | 7.13 | — | — |
| S1 | 5.19 | -1.94 | -27.26% |
| S2 | 5.97 | -1.16 | -16.32% |
| S3 | 6.36 | -0.77 | -10.75% |
| S4 | 6.75 | -0.38 | -5.38% |
LASA is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 6.76 ~ 7.54
Trading Inside opening range
Lasa Supergenerics Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Lasa Supergenerics Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Lasa Supergenerics Ltd stood at 44.6% of traded volume, against a 20-day average of 77.0%.
Lasa Supergenerics announcements: results, concalls, ratings, M&A.
Filings Lasa Supergenerics sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Lasa Supergenerics files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 48 documents below.
Disclosure under SEBI Takeover Regulations
Omkar Herlekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Updates
Lasa Supergenerics Limited has informed the Exchange regarding 'Declaration with respect to non -applicability of Large Entities'.
Updates
Lasa Supergenerics Limited has informed the Exchange regarding 'Declaration with respect to non -applicability of Large Entities'.
Lasa Supergenerics dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Lasa Supergenerics has declared, sequenced by announce and record date.
Lasa Supergenerics corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Lasa Supergenerics Ltd: business, sector, key facts.
What Lasa Supergenerics Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Lasa Supergenerics Ltd operates in the Healthcare, listed as NSE: LASA, BSE: 540702.
Lasa Supergenerics Limited is an Indian company established in 2016 that operates within the healthcare sector, focusing on both human and animal health products. Their core business revolves around the research, manufacturing, and marketing of these products, encompassing a broad spectrum of activities within the pharmaceutical and veterinary industries.
A significant portion of Lasa's business centers on the production and sale of Active Pharmaceutical Ingredients (APIs). These APIs form the foundational components of many medications and are crucial for the manufacturing of both human and animal drugs. Their API portfolio is diverse, including key substances such as fenbendazole, albendazole, closantel, and various other compounds used in treating parasitic infections and other health conditions in animals. They also produce APIs for human use, illustrating their reach across both sectors.
Beyond APIs, Lasa Supergenerics Limited manufactures and supplies animal feed ingredients. This expands their role in the animal health market, offering essential components for complete animal nutrition solutions. The inclusion of calcium iodate as a notable product highlights their commitment to providing crucial nutritional supplements for livestock.
Furthermore, the company produces and provides reagents for therapeutic applications. These reagents, such as potassium iodide, are important components used in various medical and veterinary treatments. This further diversifies their product offerings and strengthens their position within the healthcare sector.
Finally, a key aspect of Lasa's business model involves exporting its products. This international reach demonstrates their capacity to compete on a global scale and indicates a significant contribution to the international pharmaceutical and veterinary supplies market. Their operations encompass the entire chain, from research and development to manufacturing, marketing, and distribution both domestically and internationally.
Questions investors ask about Lasa Supergenerics Ltd (LASA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Lasa Supergenerics Ltd (LASA)?
The current share price of Lasa Supergenerics Ltd (LASA) is ₹7.13. Today, the stock has declined by ₹0.05 (0.70%), trading in a range of ₹6.76 to ₹7.54. The stock opened at ₹7.54 with a trading volume of 50,458 shares.
02Is Lasa Supergenerics Ltd stock a good investment for long-term?
Lasa Supergenerics Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹35.62 crores, P/E ratio of 0.00, ROE of -51.13%, and ROCE of -1.00%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Lasa Supergenerics Ltd stock?
The 52-week high price of Lasa Supergenerics Ltd (LASA) is ₹0, while the 52-week low is ₹0. Currently trading at ₹7.13, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Lasa Supergenerics Ltd stock at the current price?
Whether to buy Lasa Supergenerics Ltd stock at ₹7.13 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of 0.72. Today's performance shows a loss of 0.70%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Lasa Supergenerics Ltd and when is the next dividend?
Lasa Supergenerics Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹7.13, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Lasa Supergenerics Ltd?
Lasa Supergenerics Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: 0.72, ROE: -51.13%, ROCE: -1.00%, Dividend Yield: 0.00%, EPS: ₹-8.83, Book Value: ₹9.89, and Debt-to-Equity: 19.64. The company's market cap stands at ₹35.62 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Lasa Supergenerics Ltd stock performing today in the market?
Lasa Supergenerics Ltd stock opened at ₹7.54 and is currently trading at ₹7.13, showing a decline of ₹0.05 (0.70%). The intraday high is ₹7.54 and low is ₹6.76. The trading volume stands at 50,458 shares, indicating moderate market participation today.
08What is the P/E ratio of Lasa Supergenerics Ltd and what does it indicate?
Lasa Supergenerics Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-8.83, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Lasa Supergenerics Ltd (LASA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs & Pharmaceuticals (AKUMS) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy